CIK 0001506251 · Non-accelerated filer<br>Smaller reporting company
Citius Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CTXR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273425913
- Phone
- (908) 967-6676
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- Trail One, Inc., TrailOne, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-08 | Mazur Leonard L Chief Executive Officer | Returned to the company · Warrant to Purchase Common Stock | −125,490 | 0 | ||
| 2025-08-08 | Mazur Leonard L Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +125,490 | 125,490 | ||
| 2025-08-08 | Mazur Leonard L Chief Executive Officer | Returned to the company · Warrant to Purchase Common Stock | −89,388 | 0 | ||
| 2025-08-08 | Mazur Leonard L Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +89,388 | 89,388 | ||
| 2025-08-08 | HOLUBIAK MYRON Z Vice Chairman | Returned to the company · Warrant to Purchase Common Stock | −31,373 | 0 | ||
| 2025-08-08 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Warrant to Purchase Common Stock | +31,373 | 31,373 | ||
| 2025-08-08 | HOLUBIAK MYRON Z Vice Chairman | Returned to the company · Warrant to Purchase Common Stock | −22,344 | 0 | ||
| 2025-08-08 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Warrant to Purchase Common Stock | +22,344 | 22,344 | ||
| 2024-11-07 | Webb Carol Director | Grant or award · Stock Option (Right to Purchase Common Stock) | +125,000 | 125,000 | ||
| 2024-11-07 | Smith Robert Joseph Director | Grant or award · Stock Option (Right to Purchase Common Stock) | +125,000 | 125,000 | ||
| 2024-11-07 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +350,000 | 350,000 | ||
| 2024-11-07 | Mazur Leonard L Chief Executive Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +600,000 | 600,000 | ||
| 2024-11-07 | Czuczman Myron Chief Medical Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +300,000 | 300,000 | ||
| 2024-11-07 | Dutia Suren G Director | Grant or award · Stock Option (Right to Purchase Common Stock) | +125,000 | 125,000 | ||
| 2024-11-07 | MCGRATH DENNIS M Director | Grant or award · Stock Option (Right to Purchase Common Stock) | +125,000 | 125,000 | ||
| 2024-11-07 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Stock Option (Right to Purchase Common Stock) | +350,000 | 350,000 | ||
| 2024-11-07 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-11-07 | Holuka Eugene Myron Director | Grant or award · Stock Option (Right to Purchase Common Stock) | +125,000 | 125,000 | ||
| 2024-09-25 | HOLUBIAK MYRON Z Vice Chairman | Returned to the company · Warrant to Purchase Common Stock | −558,597 | 0 | ||
| 2024-09-25 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Warrant to Purchase Common Stock | +558,597 | 558,597 |
Page 1 of 8 · 156 trades